Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | MDT | ABT |
|---|---|---|
| Price | $89.11 | $101.69 |
| Change today | ▼ 0.21% | ▼ 1.74% |
| Market cap | $113.98B | $175.96B |
| Return, 3 months | +12.2% | +13.2% |
| Return, year to date | -5.6% | -17.3% |
| Return, 1 year | -3.9% | -22.3% |
| P/E (TTM) | 21.9 | 32.9 |
| P/B | 2.3 | 3.4 |
| P/E percentile vs own 5y | 10th | 69th |
| Dividend yield | 3.20% | 2.40% |
| Revenue growth (YoY, latest qtr) | +13.7% | +13.0% |
| Net profit growth (YoY) | +41.3% | -47.8% |
| Gross margin | 65.0% | 56.6% |
| Operating margin | 19.0% | 15.8% |
| Net margin | 13.9% | 11.6% |
| Return on equity | 10.7% | 10.7% |
| Analyst target vs. price | +16.9% | +22.3% |
| Analyst buy share | 63% | 100% |
| RSI (14) | 48 | 43 |
| 30-day volatility | 20.4% | 20.1% |
| Max drawdown, 1 year | -28.9% | -38.6% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.